The results demonstrated that inhibiting the activation of this pathway effectively diminished CCL20 secretion in TAMs and hindered the recruitment of CCR6+ Tregs, consequently reducing the proportion of Tregs and impeding tumor growth (Figure 5E–L). This evidence concerns the gene CCL20 and neoplasm.